News Archive - Page 44 of 113 - Life Sciences Scotland

Clear

Allogeneic CAR-T Specialists TC BioPharm Appoint Prof John Anderson as Scientific and Medical Director

TC BioPharm (TCB), leaders in the development of tumor-targeting gamma delta T (GDT) cells, today announced that Professor John Anderson...

29th Mar 2019

Lamellar Biomedical Expands its Product Formulation and Process Capabilities to Realise the Potential of its LAMELLASOME™ Nucleic Acid Transfer (NAT) technology

Lamellar Biomedical Limited (Lamellar), an innovative biotechnology company pioneering new approaches for the safe and effective transfer of functional nucleic...

27th Mar 2019

RoslinCT appoints David Bowie to Board of Directors

RoslinCT, a leading cell gene therapy contract manufacturing organisation, is pleased to announce the appointment of David Bowie to the...

22nd Mar 2019

Celgene and Exscientia Enter 3-year AI Drug Discovery Collaboration Focused on Accelerating Drug Discovery in Oncology and Autoimmunity

Exscientia, a world-leading Artificial Intelligence (AI)-driven drug discovery company, announced today that it has entered a three-year AI drug discovery...

21st Mar 2019

Ground Breaking Pancreatic Cancer Trial Reaches Patient Milestone

A ground breaking pancreatic cancer trial, which aims to match patients with more targeted and effective treatment for their tumours,...

20th Mar 2019

Skin swab test for Parkinson’s on horizon

A study has identified chemicals in the skin responsible for a unique scent in people with Parkinson’s disease. The chemicals...

20th Mar 2019

Learn About Our Key Subsectors

Do you have news for the Scottish Life Sciences Community?

Submit Your Own News